FDA Adverse Event Injury Summary report: N

VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT

MDR report key: 8676595 · Received June 6, 2019

Report

Report Number
2210968-2019-82501
Event Type
Injury
Date Received
June 6, 2019
Report Date
May 10, 2019
Manufacturer
ETHICON INC.
Product Code
GAM
PMA / PMN Number
K022269
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS THROUGH A JOURNAL ARTICLE. NO SPECIFIC PATIENT INFORMATION REGARDING EVENTS HAS BEEN PROVIDED AND IT IS UNKNOWN IF THE EVENTS HAVE BEEN PREVIOUSLY REPORTED. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. IF FURTHER DETAILS ARE RECEIVED AT THE LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. DOES THE SURGEON BELIEVE THAT ETHICON PRODUCTS (VICRYL SUTURE) INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH THE ETHICON PRODUCTS (VICRYL SUTURE) USED IN THIS PROCEDURE? CITATION: DISEASES OF THE COLON & RECTUM (2018); 61: 1316¿1319. DOI: 10.1097/DCR.0000000000001215. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED VIA JOURNAL ARTICLE TITLED: PERINEAL STAPLED RECTAL PROLAPSE RESECTION IN ELDERLY PATIENTS: LONG-TERM FOLLOW-UP," AUTHORS: EDWARD RAM, M.D., AVIAD HOFFMAN, M.D., YURI GOLDES, M.D., DANNY ROSIN, M.D. NIR HORESH, M.D., MORDECHAI GUTMAN, M.D., AND YAIR EDDEN, M.D. CITATION: DISEASES OF THE COLON & RECTUM (2018); 61:1316¿1319. DOI: 10.1097/DCR.0000000000001215: THE AIM OF THIS STUDY WAS TO ASSESS THE LONG-TERM RESULTS OF PERINEAL STAPLED PROLAPSE RESECTION (PSPR), FOCUSING ON MORBIDITY, RECURRENCE RATE, AND FUNCTIONAL OUTCOME. BETWEEN JANUARY 2010 TO JUNE 2013, 30 PATIENTS (2 MALE AND 28 FEMALE; AGE RANGE: 67-96 YEARS) WITH FULL-THICKNESS RECTAL PROLAPSE AND DAILY FECAL INCONTINENCE (FI) THAT WERE NOT SUITABLE FOR ABDOMINAL OR EXTENDED SURGERY THAT UNDERWENT PERINEAL STAPLED RECTAL RESECTION WERE INCLUDED IN THIS STUDY. THE OPERATION COMMENCES WITH RECTAL PROLAPSE EXTRACTION FOLLOWED BY LATERAL DIVISION OF THE PROLAPSE AT THE 3 O¿CLOCK POSITION BY USING A LINEAR STAPLER TLC75 (ETHICON) SO THAT THE STAPLER LINE ENDS 2 CM ABOVE THE DENTATE LINE. CONTOUR TRANSTAR STAPLER (ETHICON) IS INSERTED INTO THE PROLAPSED RECTUM AND TURNED IN A COUNTERCLOCKWISE FASHION OVER THE PROLAPSE EXTENT. THE STAPLE LINE WAS THEN OVERSEWN WITH A RUNNING VICRYL 2/0 SUTURE (ETHICON) TO ENSURE THE INTEGRITY OF THE STAPLE LINE AND IMPROVED HEMOSTASIS. REPORTED COMPLICATIONS INCLUDED RECURRENT RECTAL PROLAPSE (N-6) IN WHICH 4 PATIENTS UNDERWENT ALTEMEIER PROCEDURE AND 2 PATIENTS HAD A REDO-PSPR PROCEDURE, AND POSTOPERATIVE FECAL INCONTINENCE (N-30) IN CONCLUSION, FRAIL PATIENTS THAT CAN ONLY ENDURE A SHORT PROCEDURE UNDER REGIONAL ANESTHESIA SHOULD BE CONSIDERED FOR PSPR. THE LACK OF MORTALITY AND MORBIDITY, SPECIFICALLY IN THIS POPULATION, COMBINED WITH THE LOW SUSTAINING LONG-TERM RECURRENCE RATES, MAKE THIS SURGICAL ALTERNATIVE A CONSIDERABLE ONE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
467909 VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT SUTURE, ABSORBABLE, SYNTHETIC GAM ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention